BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11999556)

  • 1. Erythropoietin receptor in myelodysplastic syndrome and leukemia.
    Takeshita A; Shinjo K; Naito K; Ohnishi K; Higuchi M; Ohno R
    Leuk Lymphoma; 2002 Feb; 43(2):261-4. PubMed ID: 11999556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assay.
    Shinjo K; Takeshita A; Higuchi M; Ohnishi K; Ohno R
    Br J Haematol; 1997 Mar; 96(3):551-8. PubMed ID: 9054663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome.
    Shimizu R; Komatsu N; Miura Y
    Exp Hematol; 1999 Feb; 27(2):229-33. PubMed ID: 10029161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the erythropoietin receptor gene in patients with myeloproliferative and myelodysplastic syndromes.
    Mittelman M; Gardyn J; Carmel M; Malovani H; Barak Y; Nir U
    Leuk Res; 1996 Jun; 20(6):459-66. PubMed ID: 8709617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of erythropoietin receptor in leukemia cells and relation of erythropoietin level with leukemic anemia].
    Feng M; Li YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1265-70. PubMed ID: 19099624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia.
    Nalbant D; Saleh M; Goldman FD; Widness JA; Veng-Pedersen P
    J Pharmacol Exp Ther; 2010 May; 333(2):528-32. PubMed ID: 20103588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes.
    Di Savino A; Gaidano V; Palmieri A; Crasto F; Volpengo A; Lorenzatti R; Scaravaglio P; Manello A; Nicoli P; Gottardi E; Saglio G; Cilloni D; De Gobbi M
    Br J Haematol; 2017 Feb; 176(3):491-495. PubMed ID: 26914246
    [No Abstract]   [Full Text] [Related]  

  • 10. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR.
    McArthur GA; Longmore GD; Klingler K; Johnson GR
    Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study Group.
    Takeshita A; Shinjo K; Higuchi M; Miyawaki S; Takemoto Y; Kishimoto Y; Saito K; Takuchi H; Kuriyama K; Kimura Y; Asou N; Takahashi M; Hotta T; Kanamaru A; Ueda R; Ohno R
    Br J Haematol; 2000 Jan; 108(1):55-63. PubMed ID: 10651724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EPO and EPOR Expression in Patients with Acute Leukemia and Its Clinical Significance].
    Tian RM; Huang CS; Su Q; Shi L; Luo X; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1026-1032. PubMed ID: 31418352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
    Backx B; Broeders L; Hoefsloot LH; Wognum B; Löwenberg B
    Leukemia; 1996 Mar; 10(3):466-72. PubMed ID: 8642863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
    Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
    Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia.
    Bunworasate U; Arnouk H; Minderman H; O'Loughlin KL; Sait SN; Barcos M; Stewart CC; Baer MR
    Blood; 2001 Dec; 98(12):3492-4. PubMed ID: 11719396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
    Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of EPOR on acute leukemia cells and its clinical significance].
    Cheng GL; Wang W; Wang HY; Cui ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):15-8. PubMed ID: 21362213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
    Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
    J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
    Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
    Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.